companydata.dkcompanydata.dk

Rebsdorf Medical ApS: Financial statements 2024

CVR: 42080578

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Rebsdorf Medical ApS (CVR 42080578) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,209,669 and a net result of DKK 1,864,374 compared with DKK 126,817 the year before. Equity in the 2024 report amounted to DKK 40,000. The solvency ratio was 100%.

Gross Profit
DKK 2,209,669
Profit/Loss
DKK 1,864,374
Equity
DKK 40,000
Total Assets
DKK 40,000
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-2.2M1.9M40K0
2023--127K40K-
2022---48K40K-
2021-1.3M6K5K40K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Rebsdorf Medical ApS: The 2023 annual report is outJun 27, 2024

Rebsdorf Medical ApS has published its annual report for 2023. The net result was DKK 126,817.

About Rebsdorf Medical ApS

Rebsdorf Medical ApS is a Danish company of the type Anpartsselskab based in Fredericia, founded in 2021. The company is under bankruptcy. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company is owned by Rebsdorf Global Holding ApS. The company has 1 employee (2024). In 2024, the company reported a gross profit of DKK 2,209,669 and a net result of DKK 1,864,374 compared with DKK 126,817 the year before. Equity in the 2024 report amounted to DKK 40,000.

Source: annual report 2024, Danish Business Authority

Other financial years